Literature DB >> 1385333

Visceral leishmaniasis complicating chronic hepatitis B treated with interferon.

G Fattovich, G Giustina, F Adami.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1992        PMID： 1385333     DOI： 10.1007/bf01710800

Source DB:  PubMed          Journal:  Infection        ISSN： 0300-8126            Impact factor:   3.553


× No keyword cloud information.
  6 in total

1.  Profound CD4+ lymphocytopenia in the absence of HIV infection in a patient with visceral leishmaniasis.

Authors:  G Cozon; T Greenland; J P Revillard
Journal:  N Engl J Med       Date:  1990-01-11       Impact factor: 91.245

2.  Reduced CD4 + T cells and severe oral candidiasis in absence of HIV infection.

Authors:  C Pankhurst; M Peakman
Journal:  Lancet       Date:  1989-03-25       Impact factor: 79.321

3.  Visceral leishmaniasis in immunocompromised hosts.

Authors:  M L Fernández-Guerrero; J M Aguado; L Buzón; C Barros; C Montalbán; T Martín; E Bouza
Journal:  Am J Med       Date:  1987-12       Impact factor: 4.965

4.  Fatal leishmaniasis in renal-transport patient.

Authors:  D D Ma; A J Concannon; J Hayes
Journal:  Lancet       Date:  1979-08-11       Impact factor: 79.321

5.  Recombinant leukocyte interferon treatment of chronic hepatitis B.

Authors:  G Dusheiko; A Dibisceglie; S Bowyer; E Sachs; M Ritchie; B Schoub; M Kew
Journal:  Hepatology       Date:  1985 Jul-Aug       Impact factor: 17.425

6.  Leishmania donovani: an opportunistic microbe associated with progressive disease in three immunocompromised patients.

Authors:  R Badaró; E M Carvalho; H Rocha; A C Queiroz; T C Jones
Journal:  Lancet       Date:  1986-03-22       Impact factor: 79.321
  6 in total
  1 in total

Review 1.  Clinical toxicity of the interferons.

Authors:  T Vial; J Descotes
Journal:  Drug Saf       Date:  1994-02       Impact factor: 5.606
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.